Peer Review reports
From: Effect of PCSK9 inhibitor on lipoprotein particles in patients with acute coronary syndromes
Original Submission | ||
---|---|---|
23 Sep 2020 | Submitted | Original manuscript |
7 Oct 2020 | Author responded | Author comments - Tingting Li |
Resubmission - Version 2 | ||
7 Oct 2020 | Submitted | Manuscript version 2 |
26 Oct 2020 | Reviewed | Reviewer Report |
11 Nov 2020 | Reviewed | Reviewer Report |
20 Nov 2020 | Reviewed | Reviewer Report |
1 Dec 2020 | Author responded | Author comments - Tingting Li |
Resubmission - Version 3 | ||
1 Dec 2020 | Submitted | Manuscript version 3 |
3 Dec 2020 | Reviewed | Reviewer Report |
6 Dec 2020 | Reviewed | Reviewer Report |
9 Dec 2020 | Reviewed | Reviewer Report |
14 Dec 2020 | Author responded | Author comments - Tingting Li |
Resubmission - Version 4 | ||
14 Dec 2020 | Submitted | Manuscript version 4 |
Publishing | ||
15 Dec 2020 | Editorially accepted | |
7 Jan 2021 | Article published | 10.1186/s12872-020-01827-0 |
You can find further information about peer review here.